NCT07000448

Brief Summary

The aim of this study was to investigate whether individualized PEEP application improves respiratory function and reduces the incidence of postoperative pulmonary complications (PPCs) in patients undergoing laparoscopic total hysterectomy. Investigators hypothesized that individualized PEEP would improve pulmonary oxygenation and reduce the incidence of postoperative pulmonary complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 9, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

1.4 years

First QC Date

May 21, 2025

Last Update Submit

September 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative pulmonary complications (PPC)

    PPC included clinical conditions such as atelectasis, hypoxemia (PaO₂ \< 8.0 kPa or SpO₂ \< 90% on room air), pneumonia, acute respiratory distress syndrome (ARDS), pleural effusion, bronchospasm, pneumothorax, reintubation or need for non-invasive ventilation support.

    within 7 days after surgery

Secondary Outcomes (4)

  • Intraoperative respiratory mechanics parameter

    within intraoperative period

  • Respiratory mechanics parameter

    intraoperatively

  • Mechanic ventilation parameter

    during intraoperative period

  • Intensive care

    within 7 days after surgery

Study Arms (2)

individualized PEEP (PEEPi)

EXPERIMENTAL

In the patients in the PEEPᵢ group, a recruitment maneuver was performed after intubation and after the Trendelenburg position was given. The PEEP level was increased to 20 cmH₂O with 5 cmH₂O increments every five respiratory cycles, and an airway opening pressure of 40 cmH₂O was achieved. Dynamic compliance values observed on the ventilator monitor were recorded for optimal individual PEEP titration when PEEP reached 20 cmH₂O. The PEEP level was decreased by 2 cmH₂O every 3 respiratory cycles to determine the PEEP level at which the highest compliance value was achieved. 2 cmH₂O above this value was set as optimal PEEP, and this value was maintained throughout the surgery.

Procedure: Dynamic compliance guided individualized positive end-expiratory pressure titration strategy

PEEP 5

ACTIVE COMPARATOR

Patients in the PEEP 5 group were applied a fixed 5 cmH2O PEEP, and no recruitment maneuver was performed.

Procedure: standardized 5 PEEP

Interventions

For optimal individual PEEP titration, dynamic compliance values observed on the ventilator monitor were recorded when PEEP reached 20 cmH₂O.

individualized PEEP (PEEPi)

Patients in the PEEP 5 group were applied a fixed 5 cmH2O PEEP and no recruitment maneuver was performed.

PEEP 5

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Scheduled for elective laparoscopic total hysterectomy
  • ASA physical status I-III
  • BMI ≤30 kg/m²
  • Anticipated surgical duration \>2 hours

You may not qualify if:

  • Pre-existing neuromuscular disorders
  • NYHA class III/IV heart failure
  • OSAS
  • Previous lung surgery
  • Severe pulmonary disease (FEV1 \<50% predicted)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Istanbul, Bakirkoy, 34147, Turkey (Türkiye)

Location

Study Officials

  • Beyhan Guner, MD

    Bakırkoy Dr. Sadi Konuk Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 21, 2025

First Posted

June 3, 2025

Study Start

December 9, 2022

Primary Completion

April 25, 2024

Study Completion

June 26, 2024

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations